Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
2
RXST Quote, Financials, Valuation and Earnings
Last price:
$7.37
Seasonality move
:
-12.36%
Day range:
$7.21 - $7.60
52-week range:
$6.32 - $58.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.95x
P/B ratio:
1.06x
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
-85.27%
Market cap:
$295.8M
Revenue:
$139.9M
EPS (TTM):
-$0.67
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.7M | $22.6M | $49M | $89.1M | $139.9M | |
| Revenue Growth (YoY) | 554.98% | 53.92% | 116.9% | 81.77% | 57.09% | |
| Cost of Revenues | $13M | $18.1M | $27.7M | $35.3M | $41M | |
| Gross Profit | $1.7M | $4.5M | $21.3M | $53.8M | $98.9M | |
| Gross Profit Margin | 11.62% | 19.99% | 43.52% | 60.36% | 70.71% | |
| R&D Expenses | $21.9M | $24.5M | $26M | $29.1M | $34.4M | |
| Selling, General & Admin | $15.2M | $32.8M | $58.7M | $74.8M | $101.4M | |
| Other Inc / (Exp) | $63M | $7.7M | -- | -$1.8M | -- | |
| Operating Expenses | $37.1M | $57.3M | $84.6M | $103.9M | $135.8M | |
| Operating Income | -$35.4M | -$52.8M | -$63.3M | -$50.1M | -$36.9M | |
| Net Interest Expenses | -- | $3.6M | $3.4M | -- | -- | |
| EBT. Incl. Unusual Items | $27.6M | -$48.7M | -$66.7M | -$48.6M | -$27.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $57K | $8K | $9K | $20K | $50K | |
| Net Income to Company | $27.6M | -$48.7M | -$66.8M | -$48.6M | -$27.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $27.6M | -$48.7M | -$66.8M | -$48.6M | -$27.5M | |
| Basic EPS (Cont. Ops) | $0.18 | -$3.57 | -$2.41 | -$1.41 | -$0.71 | |
| Diluted EPS (Cont. Ops) | $0.18 | -$3.57 | -$2.41 | -$1.41 | -$0.71 | |
| Weighted Average Basic Share | $19.1M | $13.6M | $27.7M | $34.5M | $38.9M | |
| Weighted Average Diluted Share | $19.1M | $13.6M | $27.7M | $34.5M | $38.9M | |
| EBITDA | $32.2M | -$41M | -$57.8M | -$41M | -$23.8M | |
| EBIT | $28.1M | -$45M | -$61.8M | -$45.3M | -$27.4M | |
| Revenue (Reported) | $14.7M | $22.6M | $49M | $89.1M | $139.9M | |
| Operating Income (Reported) | -$35.4M | -$52.8M | -$63.3M | -$50.1M | -$36.9M | |
| Operating Income (Adjusted) | $28.1M | -$45M | -$61.8M | -$45.3M | -$27.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5M | $8.9M | $17.5M | $29.5M | $37.9M | |
| Revenue Growth (YoY) | 20.64% | 156.66% | 95.58% | 68.75% | 28.41% | |
| Cost of Revenues | $2.4M | $5.2M | $7.1M | $8.8M | $9.6M | |
| Gross Profit | $1.1M | $3.8M | $10.4M | $20.7M | $28.3M | |
| Gross Profit Margin | 32.12% | 42.06% | 59.27% | 70.09% | 74.76% | |
| R&D Expenses | $6.6M | $6.7M | $7.2M | $8M | $10.4M | |
| Selling, General & Admin | $5.6M | $13.6M | $16.3M | $23.3M | $28.6M | |
| Other Inc / (Exp) | $5M | -- | -- | -- | -- | |
| Operating Expenses | $12.3M | $20.3M | $23.5M | $31.4M | $39M | |
| Operating Income | -$11.1M | -$16.6M | -$13.1M | -$10.7M | -$10.7M | |
| Net Interest Expenses | $681K | $1M | $115K | -- | -- | |
| EBT. Incl. Unusual Items | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7K | $4K | -- | $9K | $18K | |
| Net Income to Company | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Basic EPS (Cont. Ops) | -$0.36 | -$0.64 | -$0.42 | -$0.25 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.36 | -$0.64 | -$0.42 | -$0.25 | -$0.20 | |
| Weighted Average Basic Share | $19.1M | $27.4M | $31.6M | $36.8M | $40.5M | |
| Weighted Average Diluted Share | $19.1M | $27.4M | $31.6M | $36.8M | $40.5M | |
| EBITDA | -$5.1M | -$15.5M | -$10.7M | -$7.9M | -$7.4M | |
| EBIT | -$6.1M | -$16.5M | -$11.7M | -$9.1M | -$8.2M | |
| Revenue (Reported) | $3.5M | $8.9M | $17.5M | $29.5M | $37.9M | |
| Operating Income (Reported) | -$11.1M | -$16.6M | -$13.1M | -$10.7M | -$10.7M | |
| Operating Income (Adjusted) | -$6.1M | -$16.5M | -$11.7M | -$9.1M | -$8.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.3M | $28.1M | $57.6M | $101.1M | $148.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.5M | $20.9M | $29.6M | $37M | $41.7M | |
| Gross Profit | $2.7M | $7.2M | $27.9M | $64.1M | $106.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $22.8M | $24.6M | $26.5M | $29.9M | $36.7M | |
| Selling, General & Admin | $17.1M | $40.8M | $61.3M | $81.9M | $106.7M | |
| Other Inc / (Exp) | $75.4M | $2.7M | -- | -$1.8M | -- | |
| Operating Expenses | $39.9M | $65.4M | $87.8M | $111.7M | $143.4M | |
| Operating Income | -$37.1M | -$58.2M | -$59.8M | -$47.7M | -$36.9M | |
| Net Interest Expenses | $955K | $4M | $2.5M | -- | -- | |
| EBT. Incl. Unusual Items | $37.3M | -$59.5M | -$62.4M | -$44.5M | -$26.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $59K | $5K | $5K | $29K | $59K | |
| Net Income to Company | $37.3M | -$59.5M | -$62.4M | -$44.5M | -$26.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $37.3M | -$59.5M | -$62.4M | -$44.5M | -$26.5M | |
| Basic EPS (Cont. Ops) | $0.02 | -$2.41 | -$2.20 | -$1.25 | -$0.67 | |
| Diluted EPS (Cont. Ops) | $0.02 | -$2.41 | -$2.20 | -$1.25 | -$0.67 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $42.6M | -$51.4M | -$53M | -$38.3M | -$23.2M | |
| EBIT | $38.5M | -$55.4M | -$57M | -$42.7M | -$26.5M | |
| Revenue (Reported) | $15.3M | $28.1M | $57.6M | $101.1M | $148.3M | |
| Operating Income (Reported) | -$37.1M | -$58.2M | -$59.8M | -$47.7M | -$36.9M | |
| Operating Income (Adjusted) | $38.5M | -$55.4M | -$57M | -$42.7M | -$26.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5M | $8.9M | $17.5M | $29.5M | $37.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4M | $5.2M | $7.1M | $8.8M | $9.6M | |
| Gross Profit | $1.1M | $3.8M | $10.4M | $20.7M | $28.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.6M | $6.7M | $7.2M | $8M | $10.4M | |
| Selling, General & Admin | $5.6M | $13.6M | $16.3M | $23.3M | $28.6M | |
| Other Inc / (Exp) | $5M | -- | -- | -- | -- | |
| Operating Expenses | $12.3M | $20.3M | $23.5M | $31.4M | $39M | |
| Operating Income | -$11.1M | -$16.6M | -$13.1M | -$10.7M | -$10.7M | |
| Net Interest Expenses | $681K | $1M | $115K | -- | -- | |
| EBT. Incl. Unusual Items | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7K | $4K | -- | $9K | $18K | |
| Net Income to Company | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Basic EPS (Cont. Ops) | -$0.36 | -$0.64 | -$0.42 | -$0.25 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.36 | -$0.64 | -$0.42 | -$0.25 | -$0.20 | |
| Weighted Average Basic Share | $19.1M | $27.4M | $31.6M | $36.8M | $40.5M | |
| Weighted Average Diluted Share | $19.1M | $27.4M | $31.6M | $36.8M | $40.5M | |
| EBITDA | -$5.1M | -$15.5M | -$10.7M | -$7.9M | -$7.4M | |
| EBIT | -$6.1M | -$16.5M | -$11.7M | -$9.1M | -$8.2M | |
| Revenue (Reported) | $3.5M | $8.9M | $17.5M | $29.5M | $37.9M | |
| Operating Income (Reported) | -$11.1M | -$16.6M | -$13.1M | -$10.7M | -$10.7M | |
| Operating Income (Adjusted) | -$6.1M | -$16.5M | -$11.7M | -$9.1M | -$8.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $14M | $24.4M | $11.8M | $9.7M | $16.7M | |
| Short Term Investments | $55M | $135M | $94M | $117.5M | $220.5M | |
| Accounts Receivable, Net | $2.9M | $4.9M | $11M | $20.3M | $30.1M | |
| Inventory | $8.3M | $8M | $14.8M | $17.4M | $22M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.4M | $4.1M | $3M | $3.5M | $4.5M | |
| Total Current Assets | $81.5M | $176.3M | $134.6M | $168.4M | $293.8M | |
| Property Plant And Equipment | $18.6M | $15.5M | $14.1M | $13.3M | $23.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $571K | $925K | $1.5M | $858K | $1.1M | |
| Total Assets | $100.7M | $192.7M | $150.2M | $182.6M | $318.6M | |
| Accounts Payable | $1.1M | $1.7M | $2.6M | $3.9M | $4.5M | |
| Accrued Expenses | -- | $319K | $455K | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.3M | $1.5M | $2M | $1.8M | $974K | |
| Other Current Liabilities | $5.8M | $1M | $2.3M | $2.6M | $2.8M | |
| Total Current Liabilities | $11.6M | $11.1M | $17.2M | $20.9M | $25.9M | |
| Long-Term Debt | $24.4M | $39.8M | $40.2M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $398.2M | $54.5M | $60.3M | $22.2M | $37.3M | |
| Common Stock | $80.8M | $27K | $28K | $36K | $40K | |
| Other Common Equity Adj | -$3K | -$20K | -$95K | -$5K | $166K | |
| Common Equity | -$297.5M | $138.2M | $89.9M | $160.4M | $281.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$297.5M | $138.2M | $89.9M | $160.4M | $281.2M | |
| Total Liabilities and Equity | $100.7M | $192.7M | $150.2M | $182.6M | $318.6M | |
| Cash and Short Terms | $69M | $159.3M | $105.8M | $127.2M | $237.2M | |
| Total Debt | $24.4M | $39.8M | $40.2M | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.4M | $24.1M | $11M | $32.6M | $28M | |
| Short Term Investments | $40M | $119.7M | $142.9M | $92.7M | $201.3M | |
| Accounts Receivable, Net | $2.3M | $5.6M | $12.7M | $21.6M | $31M | |
| Inventory | $9.8M | $8.5M | $18.1M | $18.7M | $23.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.4M | $3.2M | $3M | $3M | $4.5M | |
| Total Current Assets | $77.8M | $161.1M | $187.7M | $168.6M | $288.4M | |
| Property Plant And Equipment | $17.9M | $15M | $13.4M | $13.7M | $23.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $571K | $943K | $1.5M | $937K | $1.2M | |
| Total Assets | $96.3M | $177.1M | $202.5M | $183.2M | $313M | |
| Accounts Payable | $1.9M | $2.6M | $3.7M | $5.1M | $7.1M | |
| Accrued Expenses | $3.7M | $6.4M | $9.2M | $11.7M | $14.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.3M | $1.7M | $2M | $1.6M | $1.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6.9M | $10.7M | $14.9M | $18.3M | $22.7M | |
| Long-Term Debt | $29.5M | $39.9M | $40.3M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $398.2M | $53.9M | $57.5M | $19.2M | $33.7M | |
| Common Stock | $4K | $27K | $34K | $37K | $41K | |
| Other Common Equity Adj | -- | -$98K | -$9K | -$53K | $15K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$301.9M | $123.2M | $145M | $163.9M | $279.3M | |
| Total Liabilities and Equity | $96.3M | $177.1M | $202.5M | $183.2M | $313M | |
| Cash and Short Terms | $64.4M | $143.8M | $153.9M | $125.4M | $229.3M | |
| Total Debt | $29.5M | $39.9M | $40.3M | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $27.6M | -$48.7M | -$66.8M | -$48.6M | -$27.5M | |
| Depreciation & Amoritzation | $4M | $4M | $4M | $4.2M | $3.6M | |
| Stock-Based Compensation | $4.2M | $7.6M | $11.4M | $15.7M | $24.6M | |
| Change in Accounts Receivable | -$2.1M | -$2M | -$6.1M | -$9.3M | -$9.8M | |
| Change in Inventories | -$1.3M | -$2.1M | -$7.6M | -$2.7M | -$5M | |
| Cash From Operations | -$35.2M | -$44.7M | -$58.9M | -$41.6M | -$16.9M | |
| Capital Expenditures | $2.5M | $1.9M | $2.4M | $4.8M | $5.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $15.6M | -$81.9M | $40M | -$22.1M | -$99.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $25M | $15M | -- | $20M | -- | |
| Long-Term Debt Repaid | -$142K | -$27K | -$121K | -$60.2M | -$61K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$636K | $443K | -$1.4M | -$4.3M | -$5.5M | |
| Cash From Financing | $25.2M | $137.3M | $6.3M | $61.5M | $123.3M | |
| Beginning Cash (CF) | $8.8M | $14.5M | $25.2M | $12.6M | $10.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5.6M | $10.7M | -$12.6M | -$2.2M | $7.1M | |
| Ending Cash (CF) | $14.5M | $25.2M | $12.6M | $10.4M | $17.5M | |
| Levered Free Cash Flow | -$37.7M | -$46.6M | -$61.2M | -$46.4M | -$22.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Depreciation & Amoritzation | $966K | $1M | $999K | $1.1M | $785K | |
| Stock-Based Compensation | $1.2M | $2.6M | $3.3M | $4.7M | $7.1M | |
| Change in Accounts Receivable | $600K | -$764K | -$1.7M | -$1.3M | -$928K | |
| Change in Inventories | -$1.5M | -$530K | -$3.2M | -$1.4M | -$1.6M | |
| Cash From Operations | -$10.3M | -$15M | -$17.8M | -$9.3M | -$8.8M | |
| Capital Expenditures | $498K | $370K | $747K | $2M | $575K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $14.5M | $14.9M | -$48.4M | $24.3M | $20.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9K | -$44K | -$41K | -$27K | -$13K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$54K | -$362K | -$567K | -$2.1M | -$1.4M | |
| Cash From Financing | $6.1M | -$98K | $65.3M | $8M | -$735K | |
| Beginning Cash (CF) | $14.5M | $25.2M | $12.6M | $10.4M | $17.5M | |
| Foreign Exchange Rate Adjustment | -$4K | -$5K | $2K | -$3K | $6K | |
| Additions / Reductions | $10.4M | -$224K | -$824K | $23M | $11.3M | |
| Ending Cash (CF) | $24.8M | $24.9M | $11.8M | $33.4M | $28.8M | |
| Levered Free Cash Flow | -$10.8M | -$15.4M | -$18.5M | -$11.3M | -$9.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $37.3M | -$59.5M | -$62.4M | -$44.5M | -$26.5M | |
| Depreciation & Amoritzation | $4M | $4.1M | $4M | $4.4M | $3.3M | |
| Stock-Based Compensation | $4.8M | $9M | $12M | $17.1M | $27.1M | |
| Change in Accounts Receivable | -$1.6M | -$3.4M | -$7M | -$8.9M | -$9.5M | |
| Change in Inventories | -$1.2M | -$1.2M | -$10.3M | -$898K | -$5.2M | |
| Cash From Operations | -$33.2M | -$49.4M | -$61.6M | -$33.1M | -$16.5M | |
| Capital Expenditures | $2.2M | $1.8M | $2.8M | $6M | $4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $5.9M | -$81.6M | -$23.3M | $50.5M | -$102.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$96K | -$62K | -$118K | -$60.1M | -$47K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$774K | $135K | -$1.6M | -$5.8M | -$4.8M | |
| Cash From Financing | $31.3M | $131.1M | $71.7M | $4.2M | $114.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.9M | $108K | -$13.2M | $21.6M | -$4.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$35.4M | -$51.3M | -$64.4M | -$39.2M | -$20.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$17.6M | -$13.2M | -$9.1M | -$8.2M | |
| Depreciation & Amoritzation | $966K | $1M | $999K | $1.1M | $785K | |
| Stock-Based Compensation | $1.2M | $2.6M | $3.3M | $4.7M | $7.1M | |
| Change in Accounts Receivable | $600K | -$764K | -$1.7M | -$1.3M | -$928K | |
| Change in Inventories | -$1.5M | -$530K | -$3.2M | -$1.4M | -$1.6M | |
| Cash From Operations | -$10.3M | -$15M | -$17.8M | -$9.3M | -$8.8M | |
| Capital Expenditures | $498K | $370K | $747K | $2M | $575K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $14.5M | $14.9M | -$48.4M | $24.3M | $20.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9K | -$44K | -$41K | -$27K | -$13K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$54K | -$362K | -$567K | -$2.1M | -$1.4M | |
| Cash From Financing | $6.1M | -$98K | $65.3M | $8M | -$735K | |
| Beginning Cash (CF) | $14.5M | $25.2M | $12.6M | $10.4M | $17.5M | |
| Foreign Exchange Rate Adjustment | -$4K | -$5K | $2K | -$3K | $6K | |
| Additions / Reductions | $10.4M | -$224K | -$824K | $23M | $11.3M | |
| Ending Cash (CF) | $24.8M | $24.9M | $11.8M | $33.4M | $28.8M | |
| Levered Free Cash Flow | -$10.8M | -$15.4M | -$18.5M | -$11.3M | -$9.4M | |
Get RXST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RXST
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
1.06x
1.80x
Price / LTM sales
1.95x
1.65x
Growth Metrics
RXST
Sector
Revenue growth
28.41%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
128.61%
8.01%
Earnings forecast
-$0.11
-$0.20
Profitability
RXST
Sector
Profitability FY 2024
$98.9M
$47.5M
Return on invested capital
-10.39%
-16.26%
Return on assets
-9.28%
-13.27%
Return on equity
-10.39%
-18.61%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
6
Balance Sheet
RXST
Sector
Total cash
$229.3M
$35.5M
Short term investments
$220.5M
$29.7M
Total assets
$318.6M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
